|
|
| Research article summary (published 27 Feb 2007): |
MEF2C transcription factor controls chondrocyte hypertrophy and bone development.
Full Abstract
Chondrocyte hypertrophy is essential for endochondral bone development. Unexpectedly, we discovered that MEF2C, a transcription factor that regulates muscle and cardiovascular development, controls bone development by activating the gene program for chondrocyte hypertrophy. Genetic deletion of Mef2c or expression of a dominant-negative MEF2C mutant in endochondral cartilage impairs hypertrophy, cartilage angiogenesis, ossification, and longitudinal bone growth in mice. Conversely, a superactivating form of MEF2C causes precocious chondrocyte hypertrophy, ossification of growth plates, and dwarfism. Endochondral bone formation is exquisitely sensitive to the balance between MEF2C and the corepressor histone deacetylase 4 (HDAC4), such that bone deficiency of Mef2c mutant mice can be rescued by an Hdac4 mutation, and ectopic ossification in Hdac4 null mice can be diminished by a heterozygous Mef2c mutation. These findings reveal unexpected commonalities in the mechanisms governing muscle, cardiovascular, and bone development with respect to their regulation by MEF2 and class II HDACs.
Learn Faster Today Improve your study skills
Author information
Author/s: Arnold, Michael A (MA); Kim, Yuri (Y); Czubryt, Michael P (MP); Phan, Dillon (D); McAnally, John (J); Qi, Xiaoxia (X); Shelton, John M (JM); Richardson, James A (JA); Bassel-Duby, Rhonda (R); Olson, Eric N (EN);
Affiliation: Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Grants: GM08014 (Agency:NIGMS NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: Developmental cell (Dev Cell), published in United States. (Language: eng)
Reference: 2007-Mar; vol 12 (issue 3) : pp 377-89
Dates: Created 2007/03/05; Completed 2007/04/27; Revised 2007/12/03;
PMID: 17336904, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Ror2, a novel modulator of osteogenesis.
29 Sep 2007 - Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene.
29 Sep 2002 - Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
7 Nov 2006 - A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.
9 Oct 2007 - Requirement of the mouse I-mfa gene for placental development and skeletal patterning.
31 Oct 1998 - The CREB family of activators is required for endochondral bone development.
30 Jan 2001 - Genetic control of skeletal development.
29 Sep 2001 - FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod.
4 May 2007 - The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation.
9 Apr 2008 - OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro.
30 Oct 1997
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.